Filter Results:
(615)
Show Results For
- All HBS Web
(615)
- People (4)
- News (112)
- Research (425)
- Events (3)
- Multimedia (4)
- Faculty Publications (259)
Show Results For
- All HBS Web
(615)
- People (4)
- News (112)
- Research (425)
- Events (3)
- Multimedia (4)
- Faculty Publications (259)
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
executive branch and in Congress—who lacked the courage to risk political damage and take a stand on the issue. Sometimes, leaders actually set themselves up for predictable surprises. A classic example is the 1998 decision by a coalition of thirty-nine View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
Now that scientists have mapped the human gene, can drug makers map a road to unlimited riches? For John Lechleiter, Executive Vice President of Eli Lilly and Company's Pharmaceutical Products and Corporate Development, there remain more... View Details
Keywords: by Sean Silverthorne
- 01 Oct 1998
- News
Playing to Win
in turning losing teams into winners, Louis-Dreyfus has an enviable record of reshaping underperforming companies into formidable competitors. A scion of one of France's most prominent business families, he rejuvenated IMS International,... View Details
Keywords: Garry Emmons
- 01 Oct 2013
- First Look
First Look: October 1
yields-is believed to be an important factor contributing to the credit cycle. This paper analyses this phenomenon in the corporate bond market. Specifically, we show evidence for reaching for yield among insurance companies, the largest institutional holders of... View Details
Keywords: Sean Silverthorne
- 23 Jun 2003
- Research & Ideas
Historically Speaking: A Roundtable at HBS
HarperBusiness in 2003].The book analyzes the impact of this remarkable family on one of the most important companies in the world. Chandler: I've completed my book on the chemical and pharmaceutical... View Details
Keywords: by Jim Aisner
- 11 Sep 2019
- Research & Ideas
Germany May Have the Answer for Reducing Drug Prices
the Poronui Associate Professor of Business Administration. Pharmaceutical companies have long opposed efforts to regulate drug prices, arguing that prices reflect the companies’ massive research... View Details
- Profile
Evan Rachlin
experienced as a medical student, business issues are an inescapable reality for any physician. While shadowing a pediatrician in private practice, he noticed the tension between the busy physician and a pharmaceutical representative... View Details
Arjun Goyal
Dr. Arjun Goyal is a Co-Founder and Managing Director of Vida Ventures, a leading US-based life sciences venture capital firm with a ~$1.8 billion in AUM. Arjun focuses on creating and investing in companies that translate groundbreaking... View Details
Keywords: Finance
Arjun Goyal
Dr. Arjun Goyal is a Co-Founder and Managing Director of Vida Ventures, a leading US-based life sciences venture capital firm with approximately $1.7 billion in AUM. Arjun focuses on creating and investing in companies that translate... View Details
- 15 Dec 2024
- News
Agenda: Amanda E/J Morrison (MBA 2014)
TikToks, comedy-infused content, immersion in pop culture, and one-for-one donation program, the company is ensuring Julie is an essential part of every woman’s medicine cabinet. “Only 17 states require sex-ed to be medically accurate.... View Details
- 01 Dec 2017
- News
2017 in Health Care: Telemedicine Has Arrived
telemedicine services available next year to employees in states that allow it. We’re going to see a lot more investment in this area, from both established health care companies and startups. What’s next in health care? “More constraints... View Details
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
patients’ needs. Today’s doctors work in a system where they are rewarded by Medicare and insurance companies for the number and cost of the services they provide rather than by the value of those services in helping patients. In short,... View Details
- Fast Answer
Patent search: Product-associated patents
face="Open Sans"> Check company website. Some companies may lists patents associated with their products on their websites. For... View Details
- 17 Mar 2009
- First Look
First Look: March 17, 2009
Download the paper: http://www.hbs.edu/research/pdf/09-099.pdf Cases & Course MaterialsAvid Radiopharmaceuticals: The Venture Debt Question Harvard Business School Case 809-086 The CEO of a promising biotech company must decide how... View Details
Keywords: Martha Lagace
- 01 Mar 2007
- News
In Brief
Q&A with Daniel Vasella. Initially regarded by critics as too inexperienced to lead a major pharmaceutical company, Daniel Vasella (PMD 57, 1989) has set a new standard for innovation as CEO of Novartis. The Winning Season. Last year, St.... View Details
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
lumped together because they have the same mechanism, although they may look different to us, he said. What this portends commercially is up to smart companies to figure out, he said. Companies will need the... View Details
- Student-Profile
Byungyeon Kim
important Harvard’s worldwide research centers would be to his work. His second year research project involved a study of sales force compensation that resulted from a partnership with a Turkish pharmaceutical View Details
- 24 Jul 2014
- Op-Ed
Reform Tax Law to Keep US Firms at Home
Editor's Note. Given a veritable flood over the last year of corporate "inversions"—US companies that reincoporate in other countries to take advantage of favorable tax rates and business regulations—lawmakers in Washington D.C.... View Details
- 01 Feb 2002
- News
Telling the Electronic Century's Unfinished Story
consumer electronics and computers (except for software) was nearly complete. A century before, the early architects of the consumer electronics path had been three competing industrial forces: the United States, Europe, and Japan. Today, in consumer electronics, only... View Details
- 06 May 2008
- First Look
First Look: May 6, 2008
company which had been put up for sale by pharmaceutical giant Pfizer. Examining the decision from a strategic perspective, the (A) case provides brief histories of the two companies; traces the global... View Details
Keywords: Martha Lagace